| Mdivi-1 |
|
|
|
|
|
inhibitor |
Positive |
|
296 |
| Zidovudine |
|
|
|
|
|
abnormalize |
Positive |
|
307 |
| Acyclovir |
|
|
|
|
|
abnormalize |
Positive |
|
307 |
| Ganciclovir |
|
|
|
|
|
abnormalize |
Positive |
|
307 |
| Zalcitabine |
|
|
|
|
|
abnormalize |
Positive |
|
307 |
| XCT790 |
|
|
|
|
|
inhibit |
Positive |
|
308 |
| P110 |
1 µM |
30min |
|
Cultured SH-SY5Y cells incubated with MPP+ (2 mM, for 4 hours) or CCCP (5 µM, for 30 minutes). The cells were then stained with anti-Tom20 antibody (green) and Hoechst stain. |
microscopy images |
inhibit |
Positive |
|
310 |
| colchicine |
|
|
|
|
|
|
Positive |
|
185 |
| docetaxel |
|
|
|
|
|
|
Positive |
|
185 |
| Saquinavir |
|
|
|
|
|
decrease |
Positive |
|
307 |
| Rosiglitazone |
|
1, 2, 4, 7, 24, and 48 hrs |
Murine |
differentiated 3T3-L1 and C3H/10T1/2 adipocytes |
|
increase |
Positive |
|
179 |
| Rosiglitazone |
1uM |
24 and 48 hours |
Murine |
adipocytes |
Mitochondrial Staining and Quantification |
affect |
Positive |
|
179 |
| Clozapine |
|
|
|
|
|
Increase |
Positive |
|
307 |
| sertraline |
|
|
|
|
|
decrease |
Positive |
|
307 |
| Fluoxetine |
|
|
|
|
|
decrease |
Positive |
|
307 |
| sertraline |
|
|
|
|
|
Change |
Positive |
|
307 |
| Fluoxetine |
|
|
|
|
|
Change |
Positive |
|
307 |
| Berberine |
|
|
|
isolated rat muscle mitochondria |
decrease of absorbance at 540 nm with a Jasco V-560 spectrophotometer |
increase |
Positive |
|
327 |
| Acetaminophen |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Acetylsalicylic acid |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Amantadine |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Ambroxol |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Amoxicillin |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Ampicillin |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Antipyrine |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Arsenic trioxide |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Biotin |
5.6 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| lumiracoxib |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| bisacodyl |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Bupivacaine |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Busulfan |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Butein |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Caffeine |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Capsaicin |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Carbamazepine |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Cefixime |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Chlorambucil |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Ciprofloxacin |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Clodronate |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| curcumin |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Daunorubicin |
< 6.25 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| dexamethasone valerate |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Diazoxide |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Diclofenac |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Diflunisal |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Doxorubicin |
85 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Fluconazole |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Flufenamic Acid |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Flutamide |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| gefitinib |
63.6 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| genistein |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Gossypol |
> 10 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Ibuprofen |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| imipramine |
274.4 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Indomethacin |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Isoniazid |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Ketoconazole |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Lamivudine |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Lidocaine |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Lonidamine |
660 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| lovastatin |
71.5 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| lumiracoxib |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Manganese |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Mefenamic acid |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Metformin |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Nicotine |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| nifuroxazide |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Nimesulide |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Nitrofurantoin |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Perhexiline |
14.8 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Piroxicam |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| pravastatin |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| propylparaben |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Pyrazinamide |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| resveratrol |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| riboflavin |
672.3 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| rifampicin |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Salicylic acid |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Simvastatin |
173.2 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Sulindac |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Tamoxifen |
9 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Tolcapone |
> 400 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Tolfenamic Acid |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Troglitazone |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Valproic Acid |
> 800 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Zidovudine |
> 200 µM |
30 mins |
mouse |
liver mitochondria |
swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) |
increase |
Positive |
EC20 |
36 |
| Amiodarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurements of mitochondrial swelling |
increase |
Positive |
p < 0.05 |
4 |
| benzarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurements of mitochondrial swelling |
increase |
Positive |
p < 0.05 |
4 |
| benzbromarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurements of mitochondrial swelling |
increase |
Positive |
p < 0.05 |
4 |
| Clozapine |
|
|
|
|
|
|
Positive |
|
197 |
| Etoposide |
|
|
|
isolated mitochondria |
|
increase |
Positive |
|
57 |
| Cisplatin |
|
|
|
|
|
|
Positive |
|
197 |
| Chlorpyrifos |
30 μM |
|
Human |
Human induced pluripotent stem cells (iPSCs) |
|
increase |
Positive |
|
242 |
| Paraquat |
|
|
|
|
|
increase |
Positive |
|
67 |
| Mdivi-1 |
|
|
|
|
|
|
Positive |
|
248 |
| Urolithin A |
|
|
|
|
|
enhance |
Positive |
|
248 |
| Ozone |
1 μg O 3/mL |
|
|
HeLa cells |
|
|
Positive |
|
247 |
| Ozone |
10 μg O 3/mL |
|
|
HeLa cells |
|
|
Positive |
|
247 |
| Nicotine |
10 mM |
|
Human |
Human embryonal carcinoma cells (NT2/D1) |
|
|
Positive |
|
247 |
| Cisplatin |
3 mg/kg bodyweight |
twice a week for 2 weeks |
Mouse |
Mouse tibial nerves and dorsal root ganglia (L1–L4) |
|
|
Positive |
|
247 |
| Doxorubicin |
7.2 μM DXR for 24 hrs |
|
Human |
fibroblasts |
|
|
Positive |
|
247 |
| MDMA |
20 μM MDMA mixture for 24 hrs |
|
|
Mouse primary hippocampal neurons |
|
|
Positive |
|
247 |
| Metamfetamine |
0.5, 1, 2 mM Meth for 24 hrs |
|
|
Human neuroblastoma SH- SY5Y |
|
|
Positive |
|
247 |
| Troglitazone |
10 µM |
|
ZDF fa/fa rat vs ZDF lean rat |
isolated liver mitochondria |
Mitochondrial swelling as an indicator of MPT was determined by the decrease in absorbance at 540 nm on a UV-2550 spectrophotometer. |
induce |
Positive |
significantly different from ZDF lean rats (p < 0.05) |
225 |
| Perfluorooctanoic acid |
In utero exposure (GD 1–17) to 1 mg/kg bodyweight dam |
|
|
Post-natal day 91 mouse livers |
|
|
Positive |
|
247 |
| Cadmium |
In vitro: 12uM CdCl2 In vivo: 2mg/kg CdCl2 |
|
|
Rat hepatocytes |
|
|
Positive |
|
247 |
| Manganese |
Infusion of 1 μM MnCl2 |
|
|
Rat glia |
|
|
Positive |
|
247 |
| Methylmercury |
20 μM |
|
|
Human HepG2 cells |
|
|
Positive |
|
247 |
| Chlorpyrifos |
30 μM |
|
|
Human stem cell-derived neural progenitor cells |
|
|
Positive |
|
247 |
| 2,4-dinitrophenol |
50 μM DNP at 3 hours post fertilization (hpf) |
|
|
Danio rerio |
|
|
Positive |
|
247 |
| CCCP |
20 μM CCCP for 1 to 3 hours |
|
|
HeLa cells |
|
|
Positive |
|
247 |
| FCCP |
10 μM FCCP for 48 to 72 hours |
|
|
HeLa cells |
|
|
Positive |
|
247 |
| Ultraviolet B |
100 mJ/cm2 |
|
human |
Normal epidermal keratinocytes |
|
|
Positive |
|
247 |
| Ultraviolet C |
60 mJ/cm2 |
|
Mouse |
embryonic fibroblasts |
|
|
Positive |
|
247 |
| Wortmannin |
100 nM |
|
|
SH-SY5Y neuroblastoma cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
|
Positive |
|
252 |
| hydroxychloroquine |
30 μM |
|
|
SH-SY5Y neuroblastoma cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
|
Positive |
|
252 |
| Troglitazone |
10 µM |
|
Wistar rat |
Isolated rat liver mitochondria |
Measurement of MPT using vesicle-fused mitochondria ( isolated mitochondria were preincubated with micellized phospholipid containing CL or CLOOH,and then a swelling assay was performed. ) |
increase |
Positive |
|
225 |
| Troglitazone |
25 µM |
|
|
HepG2 cells |
Images from transmission electron microscopy |
abnormal |
Positive |
|
332 |
| Troglitazone |
25 µM |
|
|
HepG2 cells |
confocal laser scanning microscopy (MitoTracker Red) |
|
Positive |
|
332 |
| 3-methyladenine |
10 mM |
|
|
SH-SY5Y neuroblastoma cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
|
Positive |
|
252 |
| Bafilomycin A1 |
50 nM |
|
|
SH-SY5Y neuroblastoma cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
|
Positive |
|
252 |
| CCCP |
10 μM or 25 μM |
|
|
mouse embryonic fibroblasts (MEFs) and SH-SY5Y cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
|
Positive |
|
252 |
| earle’s balanced salt solution |
|
|
|
|
|
|
Positive |
|
252 |
| rapamycin |
|
|
mouse |
embryonic retinas |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye |
|
Positive |
|
252 |
| Cyclosporin A |
5 μM |
|
|
mouse embryonic fibroblasts (MEFs) and SH-SY5Y cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye |
block |
Positive |
|
252 |
| Nicotinamide |
5 mM |
6h |
|
SH-SY5Y cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
induce |
Positive |
|
252 |
| fisetin |
10 μM |
6h |
|
SH-SY5Y cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
induce |
Positive |
|
252 |
| Dyclonine |
|
|
mouse |
neuron |
Mitochondrial morphology and neurite area measurements |
induce |
Positive |
|
269 |
| Benoxinate |
|
|
mouse |
neuron |
Mitochondrial morphology and neurite area measurements |
induce |
Positive |
|
269 |
| Phenyl aminosalicylate |
|
|
mouse |
neuron |
Mitochondrial morphology and neurite area measurements |
induce |
Positive |
|
269 |
| genistein |
|
|
mouse |
neuron |
Mitochondrial morphology and neurite area measurements |
induce |
Positive |
|
269 |
| Celecoxib |
|
|
mouse |
neuron |
Mitochondrial morphology and neurite area measurements |
induce |
Positive |
|
269 |
| Yohimbine |
|
|
mouse |
neuron |
Mitochondrial morphology and neurite area measurements |
induce |
Positive |
|
269 |
| penfluridol |
|
|
mouse |
neuron |
Mitochondrial morphology and neurite area measurements |
induce |
Positive |
|
269 |
| pimozide |
|
|
mouse |
neuron |
Mitochondrial morphology and neurite area measurements |
induce |
Positive |
|
269 |
| Doxepin |
|
|
mouse |
neuron |
Mitochondrial morphology and neurite area measurements |
induce |
Positive |
|
269 |
| quercetin |
|
|
|
HepG |
|
|
Positive |
|
263 |
| quercetin |
|
|
|
brain |
|
|
Positive |
|
265 |
| piceatannol |
|
48hr |
|
Mfn1−/− MEFs stably expressing an Mfn1 promoter reporter construct |
Relative luciferase activity was determined in Mfn1−/− MEFs carrying the Mfn1 promoter reporter |
|
Positive |
|
276 |
| Nimesulide |
10 μM |
20 minutes |
rat; Wistar; normal |
liver mitochondria |
Measurements of mitochondrial swelling |
increase |
Positive |
ID50 |
12 |
| Nimesulide |
7.3 μM |
20 minutes |
rat; Wistar; arthritis |
liver mitochondria |
Measurements of mitochondrial swelling |
increase |
Positive |
ID50 |
12 |
| tacrolimus |
|
|
|
beta cells from isolated rat islets |
Transmission electron microscopy and 3D reconstruction of mitochondria |
decrease |
Positive |
|
322 |
| Xanthohumol |
30μM |
24hr |
|
MCF7 cells |
using the MAP1LC3II/I ratio to monitor the autophagic flux; quantifiedPMPCB staining |
block |
Positive |
|
283 |
| doxycycline |
15 µg/ml |
6 days |
|
143B osteosarcoma cells |
BN PAGE analysis, In-gel complex I activity and western blotting |
inhibitor |
Positive |
|
285 |
| Chloramphenicol |
50 μg/ml |
5 days |
|
143B osteosarcoma cells |
Blue Native Gel |
inhibitor |
Positive |
|
286 |
| Chloramphenicol |
50µg/mL |
4 days |
|
|
complex I de novo assembly analysed by BN-PAGE |
inhibitor |
Positive |
|
287 |
| MG-132 |
20 μM |
6 hr |
|
HeLa cells |
The cells were stained with MitoTracker Green FM and MitoSOX Red dyes followed by image acquisition on a confocal microscope. |
induce |
Positive |
|
291 |
| Hydrazine |
2 mM |
22-24 h |
|
primary culture rat hepatocytes, RL-34(JCRB 0247), COS-1(JCRB 9082) IAR-20(JCRB 0610) |
|
induce |
Positive |
|
292 |
| H2O2 |
0.2mM |
22hr |
|
rimary culture rat hepatocytes, RL-34,COS-1, IAR-20 |
|
induce |
Positive |
|
292 |
| Chloramphenicol |
200-300µg/ml |
22hr |
|
primary culture rat hepatocytes, RL-34,COS-1, IAR-20 |
|
induce |
Positive |
|
292 |
| Ethidium Bromide |
200-300 µg/ml, 2 |
22h |
|
RL-34, COS-1, IAR-20L cells (mouse fibrob-lasts) |
|
induce |
Positive |
|
292 |
| Erythromycin |
200 µg/ml |
22 h |
|
primary culture rat hepatocytes, RL-34,COS-1, IAR-20 |
|
induce |
Positive |
|
292 |
| Indomethacin |
0.3-0.5 mM |
22 h |
|
primary culture rat hep-atocytes, RL-34,COS-1, IAR-20 |
|
induce |
Positive |
|
292 |
| Ethanol |
12.5-500 mM |
5min |
rat |
cardiac myocytes |
|
induce |
Positive |
|
292 |
| Ethanol |
1-3% |
6hr |
|
RL-34 |
|
induce |
Positive |
|
292 |
| Niclosamide |
1, 5, and 10 uM |
3 hr (1.5-6hr) |
|
HeLa/mito-YFP |
fluorescence microscope |
induce |
Positive |
|
294 |
| Diazepam |
140μg/ml |
16hr |
|
PE cells |
Energy-dependent accumulation of ethylrhodamine ; Electron micrographs of ultrathin sections |
induce |
Positive |
|
293 |
| Teriflunomide |
|
|
|
|
|
induce |
Positive |
|
295 |
| Leflunomide |
50 μM |
48 hr |
|
HeLa cells, C2C12 muscle cells, MEF cells |
Mfn2 and Mfn1 mRNA levels; MFN2, MFN1, and porin protein levels; images of mitochondrial morphology ; |
induce |
Positive |
|
295 |
| brequinar sodium |
1 μM |
48hr |
|
C2C12 cells |
|
induce |
Positive |
|
295 |
| BGP-15 |
50 μM |
4hr |
|
WRL-68 cells |
Polyethylene glycol (PEG) fusion assay; OPA1 GTPase assay and OPA1-OPA1 interactions |
induce |
Positive |
|
297 |
| BGP-15 |
50 μM |
4hr |
|
WRL-68 cells |
mERFP-labeled WRL-68 cells |
reduce |
Positive |
|
297 |
| H2O2 |
10 μmol/10E7 cells |
4-6hr |
C2C12 mouse |
muscle myoblasts |
detected by either MitoTracker Red staining, or by mERFP transfection |
induce |
Positive |
|
297 |